Amgen Sets New Timetable for Completion of Irish Manufacturing Facility
Thousand Oaks, CA (Apr. 3)-Amgen, Inc. has provided a new schedule for the completion of a new manufacturing facility in County Cork, Ireland.
Thousand Oaks, CA (Apr. 3)-Amgen, Inc. (www.amgen.com) has provided a new schedule for the completion of a new manufacturing facility in County Cork, Ireland.
In 2006, Amgen announced plans to invest more than $1 billion in new process development, bulk protein production, and fill-and-finish facilities, with an initial target of beginning operations in the 2010 timeframe.
An Amgen official explained the company has outlined a revised schedule for starting operations based on a recently conducted periodic review of its manufacturing facilities.
The bulk manufacturing capacity is scheduled to be operational in 2012, with regulatory licensure of the facility anticipated for 2013. The process development laboratories will be constructed in conjunction with the bulk facility or as needed to support start-up of the manufacturing capacity. The fill-and-finish capacity is scheduled to be operational by 2013, with regulatory licensure anticipated by 2014.
Once fully operational, the site is expected to staff 1,100.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
